Clinical Trial Update: A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of darolutamide with androgen deprivation therapy before surgery in men with high-risk localized prostate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (ADT) (Androgen deprivation therapy)
• Darolutamide (darolutamide)

Snippet

Sponsor: Bayer | Conditions: High-Risk Localized Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING